Neuraxis, INC (NRXS) stock
NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.87+0.26 (+5.64%)
Close on Nov 18, 2026Market cap $61.16MP/E –Yield –
Neuraxis price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Neuraxis's price to sales ratio was 14.1× on Nov 11, 2026, against 8.2× a year earlier. Over the last 3 years it ranged from 1.4× to 22.2×, with a median of 8.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 14.1× | +0.8 |
| 2025 | Dec 31, 2025 | 13.3× | +6.7 |
| 2024 | Dec 31, 2024 | 6.7× | +1.3 |
| 2023 | Dec 29, 2023 | 5.4× | – |
See a number that looks wrong?